Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology · Welander Distal Myopathy

Does Welander Distal Myopathy Cause ALS?

At a Glance

No, Welander distal myopathy (WDM) does not cause ALS, nor does it turn into ALS over time. While both conditions can be linked to mutations in the TIA1 gene, WDM is a slowly progressive disease affecting muscle tissue, whereas ALS is a rapidly progressive disease attacking motor neurons.

No, Welander distal myopathy (WDM) does not cause Amyotrophic Lateral Sclerosis (ALS), nor does it turn into ALS over time [1]. It is entirely understandable to feel anxious after researching your genetics online, as the same gene responsible for WDM is also heavily featured in research about ALS and Frontotemporal Dementia (FTD) [2]. However, these are fundamentally different clinical conditions [3]. WDM is a slowly progressive disease that affects your muscle tissue, whereas ALS is a rapidly progressive disease that attacks motor neurons (the nerves that control muscles) [3][4]. There is currently no documented evidence of a single individual starting with a classic WDM muscle phenotype and longitudinally transitioning into ALS [1].

The TIA1 Gene Connection

If you search for the TIA1 gene, you will immediately find literature about ALS. This is because mutations in TIA1 can cause several different diseases that fall under a broad category called multisystem proteinopathies [1][5].

The TIA1 protein normally acts as a cellular manager during times of stress, helping to form stress granules—temporary structures that protect important cellular materials [6][7]. When the stress passes, these granules are supposed to dissolve. In both WDM and ALS, a mutation in the TIA1 gene prevents these granules from dissolving properly, causing them to turn into solid, toxic clumps of protein [2][8].

Despite sharing this underlying cellular mechanism, the way the disease manifests in your body depends heavily on how those protein clumps affect specific tissues:

  • In WDM: The protein clumping primarily damages muscle cells, typically leading to localized, slow-moving weakness in the hands and feet [4][9].
  • In ALS: The protein clumping damages motor neurons in the brain and spinal cord, leading to widespread and rapid muscle denervation (loss of nerve supply to the muscles) [10][11].

Understanding Your Specific Risk

Most cases of classic WDM are caused by a specific mutation in the TIA1 gene, often referred to as the E384K mutation [2][1]. While this mutation shares similarities with the TIA1 mutations that cause ALS (which typically occur in different parts of the gene), the clinical presentation of WDM is largely distinct [3][8].

It is important to know that in extremely rare cases, researchers have noted “phenotypic variability” within families [1]. This means that within a single family carrying the exact same gene mutation, one person might develop WDM while another develops ALS [1][12]. We understand that this fact may cause significant anxiety regarding the health of your children or siblings. Please know that this occurrence is exceedingly rare. However, because of this shared genetic link, it is highly recommended that your family members speak with a genetic counselor. A genetic counselor can help your family understand these extremely rare risks and discuss options for genetic testing and family planning.

Most importantly, for you, this does not mean that your WDM will turn into ALS. The medical literature shows that once a patient develops the myopathic (muscle-related) symptoms of WDM, they do not transition to the neurogenic (nerve-related) symptoms of ALS [1].

What to Expect from Classic WDM

Because the internet often groups all TIA1 research together, it is easy to assume the worst-case scenario. However, you should expect your WDM to behave like WDM, not ALS.

  • Slow Progression: Unlike ALS, which progresses rapidly over months to a few years, WDM progresses very slowly over decades [3].
  • Localized Symptoms: Weakness usually remains concentrated in the distal muscles (hands, wrists, lower legs, and feet), rather than spreading rapidly to the breathing or swallowing muscles as seen in ALS [13]. In daily life, this might look like gradual difficulty opening jars, buttoning shirts, or tripping over rugs.
  • Cognitive Sparing: WDM does not cause the cognitive changes or dementia (such as FTD) that can sometimes accompany TIA1-related ALS [3].

If you are experiencing new or rapidly worsening symptoms, or if you have a family history of both WDM and ALS, it is always best to discuss these changes with a neurologist who specializes in neuromuscular disorders. They can use tests like an Electromyogram (EMG)—a test that measures the electrical activity in your muscles—to confirm that your symptoms are isolated to the muscles and not involving the nerves [14][15].

Common questions in this guide

Does Welander distal myopathy turn into ALS over time?
No, Welander distal myopathy does not turn into ALS. While they share a genetic link, WDM is a slowly progressive muscle disease, and the medical literature shows that once myopathic symptoms develop, they do not transition into the rapid nerve damage seen in ALS.
Why do I see ALS mentioned when I research my Welander distal myopathy?
Mutations in the TIA1 gene can cause several conditions, including both WDM and ALS. Because researchers study this gene across multiple diseases, search results often group them together, even though the clinical outcomes are very different.
What does the TIA1 gene do in the body?
The TIA1 protein helps cells form temporary stress granules to protect important cellular materials during times of stress. In conditions like WDM, a mutation prevents these granules from dissolving, creating toxic protein clumps in the muscles.
Should my family get genetic testing for the TIA1 gene?
Because TIA1 mutations can very rarely cause different conditions within the same family, it is highly recommended that family members speak with a genetic counselor. They can explain the risks and help you decide if testing is appropriate.
How can my doctor tell the difference between WDM and ALS?
A neurologist can use an Electromyogram (EMG) to measure the electrical activity in your muscles. This test helps confirm that your weakness is isolated to the muscle tissue, as expected in WDM, rather than involving the nerves as seen in ALS.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my genetic test results, exactly which TIA1 mutation do I have, and is it considered the classic Welander mutation?
  2. 2.Does my latest EMG show only myopathic (muscle) changes, or is there any evidence of neurogenic (nerve) involvement?
  3. 3.How frequently should I be monitored to ensure my weakness is progressing at the slow rate expected for WDM?
  4. 4.Are there any specific warning signs or rapid symptom changes I should report to you immediately?
  5. 5.Given the genetics of TIA1, should my family members consider genetic counseling or screening?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Diverse Phenotypic Presentation of the Welander Distal Myopathy Founder Mutation, With Myopathy and Amyotrophic Lateral Sclerosis in the Same Family.

    Purcell N, Manousakis G

    Journal of clinical neuromuscular disease 2024; (26(1)):42-46 doi:10.1097/CND.0000000000000501.

    PMID: 39163160
  2. 2

    Disease-associated mutations affect TIA1 phase separation and aggregation in a proline-dependent manner.

    Ding X, Gu S, Xue S, Luo SZ

    Brain research 2021; (1768()):147589 doi:10.1016/j.brainres.2021.147589.

    PMID: 34310938
  3. 3

    Adult-onset dominant muscular dystrophy in Greek families caused by Annexin A11.

    Johari M, Papadimas G, Papadopoulos C, et al.

    Annals of clinical and translational neurology 2022; (9(10)):1660-1667 doi:10.1002/acn3.51665.

    PMID: 36134701
  4. 4

    A Heterologous Cell Model for Studying the Role of T-Cell Intracellular Antigen 1 in Welander Distal Myopathy.

    Carrascoso I, Sánchez-Jiménez C, Silion E, et al.

    Molecular and cellular biology 2019; (39(1)) doi:10.1128/MCB.00299-18.

    PMID: 30348840
  5. 5

    Welander Distal Myopathy-Associated TIA1 E384K Mutation Disrupts Stress Granule Dynamics Under Distinct Stress Conditions.

    Ramos-Velasco B, Alcalde J, Izquierdo JM

    Biology 2025; (14(9)) doi:10.3390/biology14091288.

    PMID: 41007432
  6. 6

    TIA-1 Is a Functional Prion-Like Protein.

    Rayman JB, Kandel ER

    Cold Spring Harbor perspectives in biology 2017; (9(5)) doi:10.1101/cshperspect.a030718.

    PMID: 28003185
  7. 7

    Tandem RNA binding sites induce self-association of the stress granule marker protein TIA-1.

    Loughlin FE, West DL, Gunzburg MJ, et al.

    Nucleic acids research 2021; (49(5)):2403-2417 doi:10.1093/nar/gkab080.

    PMID: 33621982
  8. 8

    Structural basis for T-cell intracellular antigen-1 amyloid fibril formation revealed by cryo-electron microscopy.

    Inaoka D, Miyata T, Makino F, et al.

    PNAS nexus 2025; (4(12)):pgaf388 doi:10.1093/pnasnexus/pgaf388.

    PMID: 41446360
  9. 9

    Dynamics of T-Cell Intracellular Antigen 1-Dependent Stress Granules in Proteostasis and Welander Distal Myopathy under Oxidative Stress.

    Fernández-Gómez A, Velasco BR, Izquierdo JM

    Cells 2022; (11(5)) doi:10.3390/cells11050884.

    PMID: 35269506
  10. 10

    Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia.

    Yuan Z, Jiao B, Hou L, et al.

    Neurobiology of aging 2018; (64()):160.e9-160.e12 doi:10.1016/j.neurobiolaging.2017.12.017.

    PMID: 29370934
  11. 11

    RNA-Binding Proteins Implicated in Mitochondrial Damage and Mitophagy.

    Ravanidis S, Doxakis E

    Frontiers in cell and developmental biology 2020; (8()):372 doi:10.3389/fcell.2020.00372.

    PMID: 32582692
  12. 12

    Clinical and neuropathological features of ALS/FTD with TIA1 mutations.

    Hirsch-Reinshagen V, Pottier C, Nicholson AM, et al.

    Acta neuropathologica communications 2017; (5(1)):96 doi:10.1186/s40478-017-0493-x.

    PMID: 29216908
  13. 13

    Current advance on distal myopathy genetics.

    Ranta-Aho J, Johari M, Udd B

    Current opinion in neurology 2024; (37(5)):515-522 doi:10.1097/WCO.0000000000001299.

    PMID: 39017652
  14. 14

    Spontaneous activity in electromyography may differentiate certain benign lower motor neuron disease forms from amyotrophic lateral sclerosis.

    Jokela ME, Jääskeläinen SK, Sandell S, et al.

    Journal of the neurological sciences 2015; (355(1-2)):143-6.

    PMID: 26059445
  15. 15

    Subclinical spinal muscular atrophy in a 60-year-old man.

    Palma S, Pereira P

    Neuromuscular disorders : NMD 2024; (39()):42-45 doi:10.1016/j.nmd.2024.05.004.

    PMID: 38772073

This page provides educational information about the genetic connection between Welander distal myopathy and ALS. It is not medical advice; please consult your neurologist or genetic counselor for guidance on your specific diagnosis and family risk.

Get notified when new evidence is published on Distal myopathy, Welander type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.